Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Flanders Insider Profile
4 Followers
Scott Flanders, CEO, Director at Ehealth, holds 706.02K shares in Ehealth (Ticker: EHTH), holds 0.00 shares in Dex One Corp (Ticker: DEXO). Most recently, Scott Flanders Bought ― shares of Ehealth on Aug 05, 2020 for an estimated value of 3.58M.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+10.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Scott Flanders holds in companies
Most Profitable Insider Trade
The most profitable trade made by Scott Flanders
Scott Flanders's Trading History
Ehealth
Aug 05, 2020
CEO, Director
Informative Buy
3.58M
$57.26M
Dex One Corp
―
―
―
―
List of latest transactions for each holding click on a transaction to see Scott Flanders's performance on stock
You May Also Like
Scott Flanders insider profile FAQ
What is the percentage of profitable transactions made by Scott Flanders?
The percentage of profitable transactions made by Scott Flanders is 80%.
What is the average return per transaction made by Scott Flanders?
The average return per transaction made by Scott Flanders is 10.90%.
What stocks does Scott Flanders hold?
Scott Flanders holds: EHTH, DEXO stocks.
What was Scott Flanders’s latest transaction?
Scott Flanders latest transaction was an Informative Buy of $3.58M.
What was Scott Flanders's most profitable transaction?
Scott Flanders’s most profitable transaction was an Informative Buy of EHTH stock on August 4, 2016. The return on the trade was 95.90%.
What is Scott Flanders's role in Ehealth?
Scott Flanders's role in Ehealth is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.